Until now, the results of the present work have shown that molecules associated with the insulin and adiponectin signaling pathways are decreased in women with obesity independently of the PCOS condition; moreover, these levels could be re-established with MTF treatment. The gene discussed is ADIPOQ; the disease is obesity disorder.